Literature DB >> 6706401

Trypanosoma rhodesiense: analysis of the genetic control of resistance among mice.

H C Greenblatt, C L Diggs, D L Rosenstreich.   

Abstract

Inbred mouse strains differ in their resistance to infection with the human pathogen Trypanosoma rhodesiense. Of the strains tested, C57BL/6 (B6) mice were the most resistant, and BALB/c (C) mice were among the most susceptible. The genetic basis underlying the different susceptibility of these two strains was analyzed. (CXB6)F1 progeny of either sex were more resistant than the BALB/c parent. Also, the backcross of F1 mice to the susceptible male or female BALB/c parent resulted in 52.0% susceptible (i.e., death on or before day 24) progeny, as compared with only 0.64% susceptible F1 progeny. The data suggested that resistance was the dominant phenotype and that the resistant allele was carried by the B6 parent. The presence of another locus regulating resistance to death was suggested by the facts that only a small percentage of F2 mice were susceptible and that a number of F1 and F2 mice were more resistant than their B6 parent. The locus responsible for these phenomena was presumably hypostatic in nature and carried by BALB/c mice, and its effects were only evident in the presence of other resistance genes. In addition, the observation that many of the susceptible individuals among F2 and backcross mice were more resistant than the BALB/c mice suggested that other minor genes also modulated the response of mice to infection. A set of CXB recombinant inbred mice was tested as well, and the individual strains within this set could also be placed into four groups: susceptible, intermediate, resistant, or hyperresistant. These findings are compatible with the multigenic model suggested by the Mendelian analyses.

Entities:  

Mesh:

Year:  1984        PMID: 6706401      PMCID: PMC263477          DOI: 10.1128/iai.44.1.107-111.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

Review 1.  Human and animal trypanosomiases as world public health problems.

Authors:  W E Ormerod
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

2.  Genetic control of susceptibility to T. congolense infection in inbred strains of mice.

Authors:  W I Morrison; G E Roelants; T W Pearson; M Murray
Journal:  Adv Exp Med Biol       Date:  1979       Impact factor: 2.622

3.  Trypanosoma congolense: inheritance of susceptibility to infection in inbred strains of mice.

Authors:  W I Morrison; M Murray
Journal:  Exp Parasitol       Date:  1979-12       Impact factor: 2.011

4.  Susceptibility of inbred strains of mice to Trypanosoma congolense: correlation with changes in spleen lymphocyte populations.

Authors:  W I Morrison; G E Roelants; K S Mayor-Withey; M Murray
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

5.  Intrinsic immunosuppressive activity of different trypanosome strains varies with parasite virulence.

Authors:  D L Sacks; M Selkirk; B M Ogilvie; B A Askonas
Journal:  Nature       Date:  1980-01-31       Impact factor: 49.962

6.  Experimental infections with African trypanosomes. II. Immunization of mice and monkeys with a gamma-irradiated, recently isolated human strain of Trypanosoma rhodesiense.

Authors:  R E Duxbury; E H Sadun; J S Anderson
Journal:  Am J Trop Med Hyg       Date:  1972-11       Impact factor: 2.345

7.  Trypanosoma brucei: influence of host strain and parasite antigenic type on infections in mice.

Authors:  C E Clayton
Journal:  Exp Parasitol       Date:  1978-04       Impact factor: 2.011

8.  The susceptibility of strains of mice to infection with Trypanosoma congolense.

Authors:  F W Jennings; D D Whitelaw; P H Holmes; G M Urquhart
Journal:  Res Vet Sci       Date:  1978-11       Impact factor: 2.534

9.  Infectivity and virulence of Trypanosoma (trypanozoon) brucei for mice. I. Comparison of two mouse strains.

Authors:  W J Herbert; W H Lumsden
Journal:  J Comp Pathol       Date:  1968-07       Impact factor: 1.311

10.  Genetic resistance to Trypanosoma congolense infections in mice.

Authors:  D D Whitelaw; J A Macaskill; P H Holmes; F W Jennings; G M Urquhart
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

View more
  7 in total

1.  Impaired Kupffer cells in highly susceptible mice infected with Trypanosoma congolense.

Authors:  Meiqing Shi; Guojian Wei; Wanling Pan; Henry Tabel
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes.

Authors:  Rebecca Lopez; Karen P Demick; John M Mansfield; Donna M Paulnock
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  Complete in vitro life cycle of Trypanosoma congolense: development of genetic tools.

Authors:  Virginie Coustou; Fabien Guegan; Nicolas Plazolles; Théo Baltz
Journal:  PLoS Negl Trop Dis       Date:  2010-03-02

4.  Calflagin inhibition prolongs host survival and suppresses parasitemia in Trypanosoma brucei infection.

Authors:  Brian T Emmer; Melvin D Daniels; Joann M Taylor; Conrad L Epting; David M Engman
Journal:  Eukaryot Cell       Date:  2010-04-23

5.  Distinct Contributions of CD4+ and CD8+ T Cells to Pathogenesis of Trypanosoma brucei Infection in the Context of Gamma Interferon and Interleukin-10.

Authors:  Gongguan Liu; Donglei Sun; Hui Wu; Mingshun Zhang; Haixia Huan; Jinjun Xu; Xiquan Zhang; Hong Zhou; Meiqing Shi
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

6.  Identification of an acute-phase reactant in murine infections with Trypanosoma brucei.

Authors:  S Z Shapiro; S J Black
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

7.  Female partner preferences enhance offspring ability to survive an infection.

Authors:  Shirley Raveh; Sanja Sutalo; Kerstin E Thonhauser; Michaela Thoß; Attila Hettyey; Friederike Winkelser; Dustin J Penn
Journal:  BMC Evol Biol       Date:  2014-01-23       Impact factor: 3.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.